CG

Charlotta Gauffin

Chief Scientific Officer at Dicot AB

Charlotta Gauffin is an experienced professional in the pharmaceutical and clinical research sectors, currently serving as Chief Scientific Officer at Dicot Pharma AB since July 2022. Prior roles include Head of Clinical Operations at LIDDS from March 2019 to July 2022, and Senior Clinical Project Manager at Galderma from August 2014 to March 2019. Gauffin has extensive experience as a Clinical Project Manager at Scandinavian CRO, Programme Director for Early Phase Cardiovascular & Gastrointestinal studies at Quintiles, and held various positions at Biovitrum as a Medicinal Chemist. Academic credentials include a PhD in Chemistry from Uppsala University, earned between 1990 and 1999.

Location

Uppsala, Sweden

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Dicot AB

Dicot is a pharmaceutical company focused on increasing quality of life and well-being through innovations that enhance sexual health. The company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in pre-clinical stage of development.


Headquarters

Uppsala, Sweden

Employees

1-10

Links